NCT06553274

Brief Summary

Based on the nutritional factor prediction model, the individualized nutritional management of patients with umbilical cord blood transplantation (UCBT) was carried out to observe the impact on the survival efficacy of patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
67

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Aug 2024

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2024

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

August 5, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 14, 2024

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

August 14, 2024

Status Verified

August 1, 2024

Enrollment Period

1.3 years

First QC Date

August 5, 2024

Last Update Submit

August 11, 2024

Conditions

Keywords

umbilical cord blood transplantationnutrition intervention

Outcome Measures

Primary Outcomes (6)

  • The body mass index

    Body Mass Index (BMI) is defined as a person's weight in kilograms divided by the square of their height in meters (kg/m²).

    before transplantation, Day30 , Day 60 , Day120 , Day180, 12 months after transplantation.

  • The calf circumference

    The calf circumference (cm)

    before transplantation, Day30 , Day 60 , Day120 , Day180, 12 months after transplantation.

  • The thickness of skinfold

    thickness of skinfold (mm)

    before transplantation, Day30 , Day 60 , Day120 , Day180, 12 months after transplantation.

  • Grip strength

    The grip strength (kg)

    before transplantation, Day30 , Day 60 , Day120 , Day180, 12 months after transplantation.

  • Prealbumin level

    The level of prealbumin (mg/L)

    before transplantation, Day30 , Day 60 , Day120 , Day180, 12 months after transplantation.

  • Albumin Level

    The level of Alb (g/L)

    before transplantation, Day30 , Day 60 , Day120 , Day180, 12 months after transplantation.

Secondary Outcomes (7)

  • Incidence of complications

    before transplantation, Day30 , Day 60 , Day120 , Day180, 12 months after transplantation.

  • Overall survival (OS)

    12 months after transplantation

  • Disease-free survival (DFS)

    12 months after transplantation

  • The cumulative incidence of relapse (CIR)

    12 months after transplantation

  • Non-Relapse Mortality (NRM)

    12 months after transplantation

  • +2 more secondary outcomes

Study Arms (1)

Individualized nutrition intervention

EXPERIMENTAL

Full-time clinical nutrition pharmacists evaluate the nutritional status of enrolled patients and design individualized nutrition management programs

Procedure: Individualized nutrition intervention

Interventions

After the patients were enrolled, they were given nutritional assessment by full-time clinical nutritionist and designed individualized nutritional management program, which included: Nutritional Assessment once a week for 4 weeks after Transplantation + 30 days, and nutritional assessment once a week for 4 weeks after Transplantation + 60 days, nutritional assessment every 2 weeks for 8 weeks; nutritional assessment every 4 weeks for 1 year after Transplantation + 120 days after transplantation; nutritional assessment during hospitalization in the ward and after discharge from the hospital, they were followed up in the nutrition counseling clinic or by telephone. The total energy intake was 25-35 kcal/kg/d and the protein intake was 1.2-1.5 g/kg/d. According to the"Five-step nutritional treatment principle", individual nutritional prescriptions were designed by clinical nutritionists.

Individualized nutrition intervention

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18-65 years old, conscious, with language communication skills;
  • UCBT patients to be performed;
  • Major organs without serious dysfunction;
  • The participants agreed to participate in the study and signed the informed consent form.

You may not qualify if:

  • Age \< 18 years old or \> 65 years old or with cognitive impairment can not complete this survey;
  • Failure or recurrence of transplantation;
  • Combined with severe other organ system diseases (such as severe cardiac insufficiency, autoimmune disease, active infection, severe trauma) ;
  • Patients who have difficulty collecting data to complete the nutritional intervention;
  • Patients who asked to withdraw from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital

Hefei, Anhui, 230041, China

Location

MeSH Terms

Conditions

Nutrition Disorders

Condition Hierarchy (Ancestors)

Nutritional and Metabolic Diseases

Study Officials

  • Xiaoyu Zhu, Ph.D

    The First Affiliated Hospital of University of Science and Technology of China

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Xiaoyu Zhu, Ph.D

CONTACT

Lijuan Ning, M.D

CONTACT

Study Design

Study Type
interventional
Phase
phase 2
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Based on the nutritional factor prediction model, the individualized nutritional management of patients with umbilical cord blood transplantation (UCBT) was carried out to observe the impact on the survival efficacy of patients.
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 5, 2024

First Posted

August 14, 2024

Study Start

August 1, 2024

Primary Completion

December 1, 2025

Study Completion

December 1, 2025

Last Updated

August 14, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations